FFCP PHASE1:Mm9::chr12:119156309..119156319,+: Difference between revisions
From FANTOM5_SSTAR
No edit summary |
No edit summary |
||
Line 1: | Line 1: | ||
{{FFCP|EntrezGene=NA|HGNC=|MCL_coexpression_id=11|UniProt=NA|association_with_transcript=NA|description=CAGE_peak_at_chr12:119156309..119156319,+|id=chr12:119156309..119156319,+|ontology_enrichment_celltype=|ontology_enrichment_celltype_v019_2=|ontology_enrichment_disease=|ontology_enrichment_disease_v019_2=|ontology_enrichment_uberon=UBERON:0002113!4.03e-22!14;UBERON:0003918!4.03e-22!14;UBERON:0005095!4.03e-22!14;UBERON:0007687!4.03e-22!14;UBERON:0006554!2.68e-19!16;UBERON:0001008!3.90e-18!17;UBERON:0000489!1.38e-14!21;UBERON:0000970!2.00e-11!9;UBERON:0000019!2.00e-11!9;UBERON:0000047!2.00e-11!9;UBERON:0004088!2.00e-11!9;UBERON:0002104!2.00e-11!9;UBERON:0001456!2.00e-11!9;UBERON:0003072!2.00e-11!9;UBERON:0003071!2.00e-11!9;UBERON:0004128!2.00e-11!9;UBERON:0001444!2.16e-09!11;UBERON:0000020!1.26e-08!12;UBERON:0001032!1.26e-08!12;UBERON:0004456!1.26e-08!12;UBERON:0005085!5.59e-08!13;UBERON:0003103!8.03e-07!43|ontology_enrichment_uberon_v019_2=UBERON:0002113,1.36e-19,14;UBERON:0003918,1.36e-19,14;UBERON:0011143,1.36e-19,14;UBERON:0005095,1.36e-19,14;UBERON:0007687,1.36e-19,14;UBERON:0006554,1.68e-15,18;UBERON:0001008,9.58e-15,19;UBERON:0000489,1.90e-13,21;UBERON:0003103,4.30e-07,43|phase1_expression=0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.0850432901510698,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.140444420131752,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.130120442962704,0.229902104433473,0,0.452114453507145,0,0.512454881139399,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.114248512609729,0,0,0.775809948670503,0.350679099451593,1.07502113111237,3.98547399544926,3.767969468193,0.987177311374404,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.18006109403131,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0|short_description=p@chr12:119156309..119156319,+}} | {{FFCP | ||
|DHSsupport=NA | |||
|DPIdataset=NA | |||
|EntrezGene=NA | |||
|HGNC= | |||
|MCL_coexpression_id=11 | |||
|TSSclassifier=NA | |||
|UniProt=NA | |||
|association_with_transcript=NA | |||
|cluster_id=chr12:119156309..119156319,+ | |||
|description=CAGE_peak_at_chr12:119156309..119156319,+ | |||
|id=chr12:119156309..119156319,+ | |||
|ontology_enrichment_celltype= | |||
|ontology_enrichment_celltype_v019_2= | |||
|ontology_enrichment_disease= | |||
|ontology_enrichment_disease_v019_2= | |||
|ontology_enrichment_uberon=UBERON:0002113!4.03e-22!14;UBERON:0003918!4.03e-22!14;UBERON:0005095!4.03e-22!14;UBERON:0007687!4.03e-22!14;UBERON:0006554!2.68e-19!16;UBERON:0001008!3.90e-18!17;UBERON:0000489!1.38e-14!21;UBERON:0000970!2.00e-11!9;UBERON:0000019!2.00e-11!9;UBERON:0000047!2.00e-11!9;UBERON:0004088!2.00e-11!9;UBERON:0002104!2.00e-11!9;UBERON:0001456!2.00e-11!9;UBERON:0003072!2.00e-11!9;UBERON:0003071!2.00e-11!9;UBERON:0004128!2.00e-11!9;UBERON:0001444!2.16e-09!11;UBERON:0000020!1.26e-08!12;UBERON:0001032!1.26e-08!12;UBERON:0004456!1.26e-08!12;UBERON:0005085!5.59e-08!13;UBERON:0003103!8.03e-07!43 | |||
|ontology_enrichment_uberon_v019_2=UBERON:0002113,1.36e-19,14;UBERON:0003918,1.36e-19,14;UBERON:0011143,1.36e-19,14;UBERON:0005095,1.36e-19,14;UBERON:0007687,1.36e-19,14;UBERON:0006554,1.68e-15,18;UBERON:0001008,9.58e-15,19;UBERON:0000489,1.90e-13,21;UBERON:0003103,4.30e-07,43 | |||
|phase1_expression=0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.0850432901510698,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.140444420131752,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.130120442962704,0.229902104433473,0,0.452114453507145,0,0.512454881139399,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.114248512609729,0,0,0.775809948670503,0.350679099451593,1.07502113111237,3.98547399544926,3.767969468193,0.987177311374404,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.18006109403131,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0 | |||
|short_description=p@chr12:119156309..119156319,+ | |||
}} |
Latest revision as of 20:42, 4 August 2015
Short description: | p@chr12:119156309..119156319, + |
---|---|
Species: | Mouse (Mus musculus) |
DPI dataset: | NA |
TSS-like-by-RIKEN-classifier(Yes/No): | NA |
DHS support(Yes/No): | NA |
Description: | CAGE_peak_at_chr12:119156309..119156319, + |
Coexpression cluster: | MCL_coexpression_mm9:11 |
Association with transcript: | NA |
EntrezGene: | NA |
Link to Zenbu: | ZENBU |
View on UCSC genome browser
CAGE Expression
- Click each plot point to find sample in table
Ontology-based sample term enrichment analysis<b>Summary:</b>This analysis has been performed by utilizing wilcoxon rank sum test.When the number of associated cells/tissues are > n , randomly sampled n cells/tissues are used for P value calculation with rank sum test. this process are repeated several times, and the P values are averaged on the log space <br><b>Analyst:</b> Hideya Kawaji<br><br>link to source dataset<br>data
Ontology term | p-value | n |
---|---|---|
kidney | 1.36e-19 | 14 |
kidney mesenchyme | 1.36e-19 | 14 |
upper urinary tract | 1.36e-19 | 14 |
kidney rudiment | 1.36e-19 | 14 |
kidney field | 1.36e-19 | 14 |
urinary system structure | 1.68e-15 | 18 |
renal system | 9.58e-15 | 19 |
cavitated compound organ | 1.90e-13 | 21 |
compound organ | 4.30e-07 | 43 |